Reports
Reports
Sale
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global General Surgical Devices Market Overview
3.1 Global General Surgical Devices Market Historical Value (2017-2023)
3.2 Global General Surgical Devices Market Forecast Value (2024-2032)
4 Global General Surgical Devices Market Landscape
4.1 Global General Surgical Devices Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global General Surgical Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Product Type
4.2.3 Analysis by Applications
5 Global General Surgical Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global General Surgical Devices Market Segmentation
6.1 Global General Surgical Devices Market by Type
6.1.1 Market Overview
6.1.2 Disposable Surgical Supplies
6.1.2.1 Surgical Non-woven
6.1.2.1.1 Disposable Surgical Masks
6.1.2.1.2 Surgical Drapes
6.1.2.1.3 Surgical Caps
6.1.2.1.4 Surgical Gowns
6.1.2.2 Examination & Surgical Gloves
6.1.2.3 General Surgery General Surgery Procedural Kits
6.1.2.4 Needles and Syringes
6.1.2.5 Venous Access Catheters
6.1.3 Open Surgery Instrument
6.1.3.1 Retractor
6.1.3.2 Dilator
6.1.3.3 Catheters
6.1.3.4 Others
6.1.4 Energy-based & Powered Instrument
6.1.4.1 Powered Staplers
6.1.4.2 Drill System
6.1.5 Minimally Invasive Surgery Instruments
6.1.5.1 Laparoscope
6.1.5.2 Organ Retractor
6.1.5.3 Others
6.1.6 Medical Robotics & Computer Assisted Surgery Devices
6.1.7 Adhesion Prevention Products
6.2 Global General Surgical Devices Market by Product Type
6.2.1 Market Overview
6.2.2 Handheld Devices
6.2.3 Laparoscopic Devices
6.2.4 Electro Surgical Devices
6.2.5 Wound Closure Devices
6.2.6 Trocars & Access Devices
6.2.7 Others
6.3 Global General Surgical Devices Market by Applications
6.3.1 Market Overview
6.3.2 Orthopedic Surgery
6.3.3 Cardiology
6.3.4 Ophthalmology
6.3.5 Wound Care
6.3.6 Audiology
6.3.7 Thoracic Surgery
6.3.8 Urology & Gynecology Surgery
6.3.9 Plastic Surgery
6.3.10 Neurosurgery
6.3.11 Others
6.4 Global General Surgical Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centers
6.4.4 Specialty Centers
6.4.5 Others
6.5 Global General Surgical Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America General Surgical Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe General Surgical Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific General Surgical Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America General Surgical Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa General Surgical Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Merck & Co., Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Lilly
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 3M
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bayer AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Medtronic
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Boston Scientific Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 B. Braun SE
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Cardinal Health, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Organogenesis Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CONMED Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Erbe Elektromedizin GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Integra LifeSciences
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BD
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Straub Medical AG
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Varian Medical Systems, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Elekta
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Isoray Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Mevion Medical Systems.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Olympus Corporation
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 Brainlab AG
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global General Surgical Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global market of surgical devices attained a value of USD 16.72 billion.
The market is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032 to reach a value of USD 35.14 billion by 2032.
The major drivers of the industry, such as the increase in the demand for surgical procedures, growing prevalence of cardiovascular and gastrointestinal diseases, growing adoption of sophisticated surgical equipment owing to the increased government expenditure, and the rising technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the increasing demand for minimally invasive surgical procedures and the growing inclination towards computer-assisted robotic surgery.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Handheld, laparoscopic, electro surgical, wound closure, and trocars and access devices, among other products, are the leading products of general surgical devices in the industry.
The significant applications of the product include gynaecology and urology, cardiology, orthopaedic, and neurology, among other applications.
The major players in the industry are B. Braun Melsungen AG, Boston Scientific Corporation, Cadence Inc., Integer Holdings Corporation, Johnson & Johnson, Medtronic, Olympus Corporation, and Stryker Corporation, among others.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.